Welcome to the International Symposium on Polymer Therapeutics to be held in Valencia.A chance for world-renowned scientists to share their recent research and vision for the future of Polymer Therapeutics to attendees in the context of interdisciplinary research at the interface of biology, chemistry, pharmaceutical sciences, and medicine.
A chance for world-renowned scientists to share their recent research and vision for the future of Polymer Therapeutics to attendees in the context of interdisciplinary research at the interface of biology, chemistry, pharmaceutical sciences, and medicine.
.
Conselleria de Sanitat, Generalitat Valenciana, SP
Director CIPF, SP
CIPF, Conference Chair
Discussion Leader: Matthias Barz (Univ Leiden, NL)
11.30 Mustafa Diken (BioNTech, DE) mRNA vaccines for cancer and beyond
Univ Leiden, NL
BioNTech, DE
Discussion leader: Julen Oyarzabal (Tyris Therapeutics Spain)
12.15 Daniel Siegwart (UT Southwestern Medical Center, USA)
Zwitterionic phospholipidation of cationic polymers facilitates systemic mRNA delivery to the spleen and lymph nodes.
12.45 Satoshi Suchida (Kyoto Prefectural University of Medicine, JP) Polymer Therapeutics for efficient mRNA delivery
13:15 Yao Jin (Ludwig-Maximilians-University Munich, DE) Synthesis and application of spermine-based poly(β-amino Ester)s for siRNA delivery
13.25 Zerong Ma (UNSW Sydney, AUS) Miktoarm star polymer nanoparticles enable siRNA delivery for the treatment of lung cancer
13.35 Stefano Salmaso (Univ Padova, IT) Lipoplex-Mediated Oligonucleotide Delivery: Enhanced Crossing of Cell Barriers
13.40 Gabriela Arias Alpizar (Univ Leiden, NL) Elucidating Nanoparticle Behavior Using Zebrafish
13.45 Anna Scomparin (Univ Turin, IT) Alkylic-Cyclodextrin Cationic Polymers: A Novel siRNA Delivery System for Glioblastoma Therapy
Tyris Therapeutics Spain
UT Southwestern Medical Center, USA
Kyoto Prefectural University of Medicine, JP
Enjoy our poster exhibition during lunch time.
Discussion Leader: Ronit Satchi-Fainaro (Tel Aviv Univ, IL)
15.15 Susan N. Thomas (Georgia Tech, USA) Polymer drug delivery systems
for immunotherapeutic drug delivery to the lymphatic system
15.45 Lutz Nuhn (Univ Mainz, Germany) Macromolecule-Based Strategies For
Enhancing Immunotherapy Responses By Macrophage Repolarization
16.15 Helena Florindo (Univ Lisbon, PT) Multivalent Anticancer NanoVaccines
16.45 Bárbara Ibarzo Yus (UCL, UK and IBEC, SP) PMPC-PDPA polymersomes in cancer vaccine development
16.55 Liane Moura (iMed. ULisboa, PT) Multivalent branched poly-l-glutamic acid-based nanovaccine sensitizes melanoma to anti-PD1 therapy
17.05 Francesca Mastrotto (Univ Padova, IT) Mannosylated polycations for therapeutic nucleic acid Delivery in cancer vaccination
Tel Aviv Univ, IL
Georgia Tech, USA
Univ Mainz, Germany
Univ Lisbon, PT
Enjoy our poster exhibition during lunch time.
An Interactive Session
17.45 – 19:15 Round Table Discussion: Including topics such as identifying Unmet needs: Drug targets and Diseases, Modalities needs – expanded space; Patient’s needs; Needs on Clinical Translation, such as, Characterization techniques and other capabilities or New advances on disruptive polymer sciences.
Discussion co-Leaders:
Marianne B. Ashford (AstraZeneca, UK) and Manuel Sánchez-Félix (Novartis, USA).
Ruth B. Schmid (Sintef, No)
Cameron Alexander (Univ Nottingham, UK)
(AstraZeneca, UK)
(Novartis USA)
(Sintef ,No)
(Univ Nottingham, UK)
Interactive session
Discussion Leader: Andrew Lewis (Quotient Sciences, UK)
9.00 Maria Kavallaris (UNSW, AUS)
(UNSW, AUS) Advanced Diagnostics and Therapeutics for Pediatric Cancers
Quotient Sciences, UK
UNSW, AUS
Discussion Leaders: Andrew Lewis (Quotient Sciences, UK)
9.45 Maria J. Blanco (Univ Navarra, Sp) Nanomedicines for the treatment of
Pediatric diseases
10.15 Mohammed Balogun (CSIR, SouthAfrica) Rational Design of Polymer Conjugates for the treatment of malaria in children
10.45 Gloria García Palacios (Sanofi. France) Overview of EU and FDA Pediatric Regulations
11.15 Tetiana Melnyk (CIPF, SP) A Polyglutamate-Based Intranasal Drug Delivery Platform for Pediatric Glioma Treatment.
Quotient Sciences, UK
Univ Navarra, Sp
CSIR, SouthAfrica
Sanofi. France
Enjoy our poster and Exhibition.
11:45 Paco Fernandez-Trillo (Univ Birmingham, UK)
Delivery of Antimicrobials through Peptide and Responsive Chemistry
11:55 Patrick Weber (ETH Zürich, SW)
Zwitterionic polymer-drug conjugates with lubricating, anti-inflammatory activity for the treatment of osteoarthritis
12:05 Elaine Ferguson (Cardiff Univ, UK)
Dextrin conjugation prevents colistin-induced acute kidney injury in mice
12:15 Tommaso Tedeschini (Univ Pavoda, IT)
Pegylated peptide-cleavable linkers designed to provide stable and active antibody-drug conjugates.
12:25 Silvia Acosta-Gutierrez (UCL, UK)
A Multiscale Study of Phosphorylcoline Driven Cellular Phenotypic Targeting
12:30 Zsuzsa Baranyai (INMA, SP)
Antitubercular Drug Delivery with Polysaccharide-Based Nanocarriers
12:35 Alexander Lamoot (Univ Ghent, BE)
Lipid Nanoparticles encapsulating PolyI:C A Potent Adjuvant for Recombinant Spike S1 SARS-CoV-2 vaccination
12.40 Antonella Grigoletto (Univ Padova, IT)
Stability and in-vivo profile of a new circular site-specific PEGylated G-CSF
CIPF, SP
Discussion Leaders: Michael Wagner (DE)
12.45 Cristianne Rijcken (Cristal Therapeutics, NL)
Conception till Clinical Translation of Core-Crosslinked (CRIPEC®) Polymeric Micelles and Product Diversification
13.15 Michael Bevilacqua (Amicrobe, USA)
AmicidinsTM: Synthetic Biologics Headed into Clinical Trials in Surgery and Trauma
Enjoy the poster and Exhibition during Lunch time
Session in honor to Prof Hiroshi Maeda. Father of the EPR effect and a Giant in our field
15.00 – 16:45 Round Table Discussion: Fundamentals of EPR and tumor targeting, on novel insights related to transcytosis, hitchhiking and macrophage retention, on practical aspects of dealing with EPR variability, and on how to move “passively targeted” cancer nanomedicines forward both clinically and industrially.
Discussion Leader: Twan Lammers (RWTH Aachen University Clinic, DE)
Milles A. Miller (MGH Center Systems Biology, Harvard Med School, USA)
Khaled Greish (Al-Jawhara Centre, Kingdom of Bahrain)
Warren Chan (Univ Toronto, CA
RWTH Aachen University Clinic.
(MGH Center Systems Biology, Harvard Med School, USA)
(Al-Jawhara Centre, Kingdom of Bahrain)
(Univ Toronto, CA)
Discussion Leader: Ana Armiñán (CIPF, SP)
16:45 Fernanda Rodríguez-Otormín (CIPF, SP) A rationally designed polypeptide-based combination conjugate for the treatment of metastatic triple negative breast cancer
16:50 Mariana Bento (iMed Univ Lisboa, PT) Multifunctional Polymeric Nanoplatform to Overcome Pancreatic Cancer Immune Evasion
16:55 Paul Strasser (Johannes Kepler University Linz, Aus) Bottlebrush, High-Molecular-Weight Polyphosphazene-G-Poly (L-Glutamic Acid) As Fully Biodegradable Polymer Therapeutics
17:00 Paz Boix-Montesinos (CIPF, SP) The Development and Characterization of Advanced In Vitro Models for the Evaluation of Polypeptide-Drug Conjugates
17:05 Diana Matias (UCL, UK) Polymersomes With Tunable Avidity to LRP1 In Healthy and Glioma Model
17:10 Carmen Moya-Lopez (Univ Lorraine, FR) Multifunctional PLA/Gelatin Bionanocomposites for Tailored Drug Delivery Systems
17:15 Antoni Serrano (CIPF, SP) Optimization of Preclinically Relevant Three-Dimensional Prostate Cancer Models
CIPF, SP
Interactive Session
Discussion Leaders: Cameron Alexander (Univ Nottingham, UK)
17:45 Adam Gormley (Rutgers Univ , USA)- Discovering Advanced polymeric systems by an Automated and AI-driven polymer chemistry platform.
18.15 Roey Amir (Tel Aviv Univ, IL) Architectural changes as a tool for controlling the stability and reactivity of polymeric assemblies.
18.45 Robert Luxenhofer (Helsinki Univ, FI), and Ann-Christin Pöppler (Univ Würzbug, DE) Taking up the chase with NMR Spectroscopy – From structural
insights into solid drug-polymer formulations to their fate in biorelevant media.
19.15 – Sebastien Rouzeau (Tosoh Biosciences, DE) Polymer therapeutics deserve a better light
Univ Nottingham, UK
Rutgers Univ , USA
Tel Aviv Univ, IL
Helsinki Univ
Univ Würzbug, DE
Tosoh Biosciences, DE
Interactive Session
* Refreshment will be provided
Discussion Leader: María J. Vicent (CIPF, SP)
9.00 Anand Subramony (AstraZeneca, USA) Targeted Nanomedicines
Bench to Bedside
CIPF, SP
AstraZeneca, USA
Discussion Leaders: Peter Turecek (Takeda, Austria)
09.45 Marisol Quintero (Highlight Therapeutics, SP) BO-112: local immunotherapy for Advanced tumors. Phase I-II studies.
10.15 Anthony Cheung (Engene Therapeutics, Canada)
EG-70: A clinical stage drug candidate for non-muscle invasive bladder cancer utilizes a novel polymer-based non-viral vectors for delivery of immune modulators
Takeda, Austria
Highligth Therapeutics, SP
Engene Therapeutics, Canada
Enjoy our poster Exhibition.
Discussion Leader: Giuseppe Battaglia (UCL, UK and IBEC, SP)
11.15 Ronit Satchi-Fainaro (Tel Aviv Univ., IL) Modulating the Brain Immune System
11.45 Daniel Gonzalez-Carter (IBEC, SP) Exploiting the physiology of the blood-brain barrier to generate artificial brain targets for polymeric nanoparticle delivery
12.15 Inmaculada Conejos-Sánchez (CIPF, SP) Treating Neurodegeneration with A Polypeptide-Based Combination Approach Tackling Oxidative Stress and Inflammation Pathways
12.30 Marcelo Calderón (POLYMAT, SP) Multiresponsive nanogels for transmucosal drug delivery
12.45 Alexander N. Zelikin (Aarhus University, Denmark) Polymer therapeutics + albumin and/or antibodies = superior drug carriers
13.00 Snežana Đorđević (CIPF, SP) Mass Spectrometry Imaging as an Emerging Tool for the Rational Design of Polypeptide-Drug Combination Conjugates
13:05 Camilla Pegoraro (CIPF, SP) The Development of Novel Polypeptide-Based Drug Delivery Platforms for Mitochondrial Targeting
13:10 Rafael Miravet Martí (PTS, SP) Poly(sarcosine)-VitE (TPSS) as alternative to poly(ethylene glycol)- VitE (TPGS).
UCL, UK and IBEC, SP
Tel Aviv Univ., IL
IBEC, SP
Promega, USA
Enjoy the poster and Exhibition during Lunch time
Discussion Leaders: Vicent J Nebot (PTS SL, SP)
14.45 Gianfranco Pasut (Univ Padova, IT) The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines
15.15 Matthias Barz (Leiden Univ, NL) Polysarcosine: More than an Alternative to PEG?
15.45 Nicola Tirelli (IIT, NIT) Protein Conjugation with Ros-Scavenging Polymers
16.00 – 17.15 Round Table Discussion. Understanding when PEG and its alternatives should be use.
Discussion Leaders: Gianfranco Pasut (Univ Padova, IT) and Matthias Barz (Leiden Univ, NL)
Vicent J Nebot (PTS, SP)
Ralf Kraehmer (Celares, DE)
Peter Turecek (Takeda, Austria)
PTS, SP
Univ Padova, IT
Leiden Univ, NL
Celares, DE
Takeda, Austria
Discussion Leader: Alexander Zelikin (Aarhus Univ, DK)
17.30 Fabian Kiessling (Univ Aachen, Germany) Polymer-based Molecular Imaging probes, Theranostics and Companion diagnostics
18.00 Eric Allémann (Université de Genève, SW) Vascular-Targeted Micelles as MRI Contrast Agents for Molecular Imaging
18:30 Christopher Eggers (Promega, USA) Bioluminescence-Based Assays for Monitoring Delivery of Therapeutic Molecules into Live Cells.
18:45 Valentino Barbieri (UCL, UK) Hybrid Au-polymer vesicles as photoactivated nanomedical devices
18:55 Roman A. Barmin (RWTH Aachen University Hospital, DE) Surfactants to tailor the acoustic response and drug loading capacity of PBCA-based polymeric microbubbles
19:05 María Alleva (INMA, SP) Interaction between polysaccharide nanocapsules and biological barrier models
19:10 María Medel (CIPF, SP) The Design of Polypeptide-Based Nanoconjugates as Advanced Theranostics
19:15 Mohit Kumar (IBEC, SP) In situ Labelling and STED Based Super Resolution Imaging of Peptide Nanostructures
Aarhus Univ, DK
Univ Aachen, Germany
Université de Genève , SW
Great opportunities for the active participation of young scientists from around the world through a number of Travel Grants to support attendance.
News on industrial and medical progress in the transfer of Polymer Therapeutics from the laboratory to the clinic.
Contact us in case you have any doubts or issues
Thanks to the support of all the collaborators for making this Symposium and exhibitors possible and with the power to transfer the knowledge of the sector
The 13th edition of the ISPT Conference will be held at: